Podcasts about merck's covid

Hunter Biden is asking federal agencies to investigate the possible illegal handling of personal data from his infamous laptop. This marks the first time he's acknowledged the laptop was really his. A new study shows that Merck's COVID drug Lagevrio causes new mutations of the virus in patients. California officials are looking to enact more gun control laws with specific limits on concealed carry. The push comes after recent shootings in the state left dozens of people dead and wounded. ⭕️Watch in-depth videos based on Truth & Tradition at Epoch TV

Today, in episode 510, our expert Infectious Disease Doctor and Community Health Specialist discuss what you need to know about Public Health. We talk about how lockdowns in China have been spreading, as well as how Merck's COVID-19 pill has been heavily used despite concerns. As always, join us for all the Public Health information you need, explained clearly by our health experts. Website: NoiseFilter - Complex health topics explained simply (noisefiltershow.com) Animations: NoiseFilter - YouTube Instagram: NoiseFilter (@noisefiltershow) • Instagram photos and videos Facebook: NoiseFilter Show | Facebook TikTok: https://www.tiktok.com/@noisefiltershow --- Send in a voice message: https://anchor.fm/noisefilter/message

In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with Dr. Kimberly Shriner, director of Infectious Disease and Prevention at Huntington Hospital in Pasadena.  Topics today include:  Pfizer's CEO says a fourth dose of COVID-19 vaccine will be needed. Pfizer is working on a shot to handle all variants.  Pfizer and BioNTech seeking approval for a second COVID-19 booster shot for those 65 and over.  Merck's COVID-19 pill heavily used so far despite concerns.   The latest surge in Asia and Europe.  White House says funding is running out for COVID-19 vaccination, testing, and treatment programs.   This program is made possible in part by the Corporation for Public Broadcasting, a private corporation funded by the American people.   

Meanwhile in Australia, over half the people in hospital ICUs have been vaxxed with Merck's Covid-19 bioweapon!Also, Dr. Darren Beattie of Revolver.news breaks NEW Jan 6 false flag information & discusses the Democrat party's announcement that they are seeking the indictment of Trump to stop him from running in 2024!

The winter COVID surge is well under way in the United States, leading to dubious new records. About one million cases were recorded Monday which surpassed the old record of 590-thousand set just last week. Can the country's healthcare system withstand the onslaught of cases and hospitalizations?  If that's not bad enough...there's a new variant found in southern France that has some scientists worried. Meanwhile hospitals are having a tough time finding enough of Pfizer's and Merck's COVID pills just as they're filling up.  Students are exhausted, stressed and burned out from the pandemic. Many of them are struggling with mental health issues and the constant changes when it comes to schools opening and closing. And finally.........COVID has exposed some major holes in America's system of caregiving for the children, the elderly and those in need. Learn more about your ad choices. Visit podcastchoices.com/adchoices

The winter COVID surge is well under way in the United States, leading to dubious new records. About one million cases were recorded Monday which surpassed the old record of 590-thousand set just last week. Can the country's healthcare system withstand the onslaught of cases and hospitalizations? If that's not bad enough...there's a new variant found in southern France that has some scientists worried.Meanwhile hospitals are having a tough time finding enough of Pfizer's and Merck's COVID pills just as they're filling up. Students are exhausted, stressed and burned out from the pandemic. Many of them are struggling with mental health issues and the constant changes when it comes to schools opening and closing.And finally.........COVID has exposed some major holes in America's system of caregiving for the children, the elderly and those in need. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

The Winter COVID surge is leading to new records here in the U.S. About one million cases were recorded Monday which surpassed the old record of 590,000 set just last week. Can we withstand the onslaught of cases and hospitalizations?If that's not bad enough, there's a new variant found in southern France that has some scientists worried. And if that's not bad enough, hospitals are having a tough time finding enough of Pfizer's and Merck's COVID pills just as they're filling up. Students are exhausted from the pandemic. Many of them are struggling with mental health issues and the constant changes when it comes to schools opening and closing.If you're wondering about the risk of catching COVID if you leave your house, try telling an app your plans. But could that lead to more anxiety?We know all about traffic here in southern California but people were stuck in the snow for hours and hours and hours in Virginia. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

The Winter COVID surge is leading to new records here in the U.S. About one million cases were recorded Monday which surpassed the old record of 590,000 set just last week. Can we withstand the onslaught of cases and hospitalizations? If that's not bad enough, there's a new variant found in southern France that has some scientists worried.  And if that's not bad enough, hospitals are having a tough time finding enough of Pfizer's and Merck's COVID pills just as they're filling up.  Students are exhausted from the pandemic. Many of them are struggling with mental health issues and the constant changes when it comes to schools opening and closing. If you're wondering about the risk of catching COVID if you leave your house, try telling an app your plans. But could that lead to more anxiety? We know all about traffic here in southern California but people were stuck in the snow for hours and hours and hours in Virginia. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with Dr. Shruti Gohil professor of medicine and associate medical director for epidemiology and infection prevention at UC Irvine's School of Medicine. Topics today include: FDA authorizes Merck's COVID-19 pill, but stresses its use should be limited.  Why does the Omicron variant spread so easily?  Biden announced 500 million free test at-home test kits, but when will they be available?  The changing definition of “fully vaccinated” as Omicron spreads.  After the flu virtually disappeared last year, it's made an unwelcome comeback.  Study suggests three doses of China's Sinovac vaccine fails to protect against Omicron.  ‘Staggeringly fast rise' in L.A. County coronavirus cases triggers alarm.  Experts say that Covid-19 is shifting towards becoming an endemic disease.  Omicron surge further complicates a year filled with unruly passengers for airlines.  Israel considers approving fourth vaccine dose.  Israel agreed to trade data on their vaccination efforts in exchange for locking down a supply, now privacy concerns have arisen.  As Omicron spreads, older americans are displaying a mix of worry and resolve.  California will send at-home tests to K-12 students.  This program is made possible in part by the Corporation for Public Broadcasting, a private corporation funded by the American people. 

US stocks fell Wednesday. Plus, Twitter changes privacy rules, Merck's COVID pill is closer to authorization, and Toys R Us opens its first store since acquisition.

Here's what's in the news today:Stacey Abrams is running for Governor again (NPR)The Supreme Court is leaning towards upholding Mississippi's 15-week abortion ban (NY Times)Barbados has officially become a Republic! (AP News)Alec Baldwin now says he didn't pull the trigger on the set of Rust (NY Times)A fourth student has died after Monday's high school shooting in Oakland County, MI (Buzzfeed News)The Women's Tennis Association is suspending all tournaments in China (NPR)The Omnicron variant has officially been found in the US (CNN)The FDA narrowly approved Merck's Covid pill (NY Times)Dr. Oz is running for the Senate (NY Times)

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the omicron variant, vaccine mandate challenges and pending FDA authorization for Merck's COVID pill.

US stocks fell Wednesday. Plus, Twitter changes privacy rules, Merck's COVID pill is closer to authorization, and Toys R Us opens its first store since acquisition.

A Food and Drug Administration advisory panel has narrowly endorsed the use of Merck and Ridgeback Biotherapeutics' oral Covid treatment pill, despite questions about the drug's effectiveness, safety and whether it would help the virus mutate into even more dangerous variants. CNBC's Meg Tirrell reports on questions about the safety of a Merck antiviral pill intended to fight Covid. Brown University School of Public Health Dean Dr. Ashish Jha also discusses the omicron Covid variant and just how impactful current vaccines could be against it. Drug lord El Chapo's wife Emma Coronel Aispuro has been sentenced to three years in prison after she pleaded guilty to money laundering and helping her husband's cartel traffic cocaine, meth and heroin into the U.S. WEYI reporter Stephanie Parkinson reports on another school shooting, this one in Michigan, where a 15-year-old killed three students and wounded 8 more people, including a teacher. Former Notre Dame football coach heading to LSU and Oklahoma's Lincoln Riley leaving for big, big money with USC in Los Angeles. Author and ESPN commentator Paul Finebaum joins Smith to discuss. Plus, CNBC's Eamon Javers reports on hackers that are offering holiday deals for illegal items on the dark web.

The origins of the omicron variant remain a mystery but it's possible it's been around for a while now. Omicron is making stock market investors and traders nervous. Merck's COVID treatment drug might not be as strong as once believed. Pharmacies are struggling with a shortage of pharmacists and other workers. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Bill Handel hosts KTLA 5's Tech Guy Rich DeMuro for this week's edition of 'Tech Tuesday'. He and Handel do a little Cyber Monday recap and talk about a robotic pizza truck opening in LA. Wayne Resnick and Jennifer Jones Lee join Bill for the Late Edition of Handel on the News. The three of them discuss news topics that include: The Omicron variant of COVID-19 was detected in the Netherlands days before it was first reported in South Africa, the CEO of Moderna says the existing vaccines against COVID-19 will struggle with Omicron, and the FDA panel will review Merck's COVID pill designed to reduce hospitalization and deaths related to the flu.

3 students dead after a shooting at a high school in Oxford, Michigan // Stocks begin to fall because of the Omicron variant // Kim Potter will testify at trial in Daunte Wright's death // A panel of advisors from the FDA are voting to authorize Merck's Covid pill // Trump, Clinton, Prince Andrew is mentioned by Epstein's ex-pilot in Maxwell trial // Adele announces her Las Vegas residency.

Cyber Monday sales figures came in roughly the same as last year's as smaller discounts offered holiday shoppers less incentive to spend. The Federal Trade Commission is asking Walmart, Amazon and other companies about supply-chain issues. Fed Chairman Jerome Powell and Treasury Secretary Janet Yellen are set to testify before Congress today. Keith Collins hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices

In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with Doctor Kimberly Shriner, director of Infectious Disease and Prevention at Huntington Hospital in Pasadena.  Topics today include:  The Omicron variant is coming, but we can prepare  CDC urges all adults to get COVID-19 boosters as the Omicron variant looms.  Regeneron's monoclonal antibody treatment is not as effective against the Omicron variant, according to preliminary tests.  Omicron variant isn't likely to cause severe illness for vaccinated individuals, according to BioNTech founder.  Moderna's chief executive predicts current vaccines will struggle against the Omicron variant. Low income L.A. County residents are less likely to get COVID-19 vaccines.  Merck's COVID-19 treatment pill is being reviewed by the FDA.  FDA is moving to authorize COVID-19 booster shots for 16 and 17 year-olds.  Tomorrow is World AIDS Day; we look at the history of the disease and how treatments have evolved. This program is made possible in part by the Corporation for Public Broadcasting, a private corporation funded by the American people.

The origins of the omicron variant remain a mystery but it's possible it's been around for a while now.Omicron is making stock market investors and traders nervous.Merck's COVID treatment drug might not be as strong as once believed.Pharmacies are struggling with a shortage of pharmacists and other workers. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

It's been 289 days under the false administration. The Dead Kennedys missed their appointment in Dallas to correct everything and give us a second Halloween. Jerks. Also, just like always, the Dems are lost and kind of suck. Other Titles Considered Single Mingle Podcast Slav Squatting Rifle Soaking Special Show Links: Massive Study Finds No Link Between Time Spent Playing Video Games And Wellbeing https://digest.bps.org.uk/2021/11/04/massive-study-finds-no-link-between-time-spent-playing-video-games-and-wellbeing/ Britain approves Merck's COVID-19 pill in world first https://www.reuters.com/business/healthcare-pharmaceuticals/britain-approves-mercks-oral-covid-19-pill-2021-11-04/ At Least 10 Republicans Who Were At The Jan. 6 Rally Just Got Elected To Office https://www.huffpost.com/entry/january-6-capitol-riot-republicans-elected-to-office_n_6181bc04e4b0ad6f587b79a8 Virginia Loss: Corporate Democrats Have Only Themselves to Blame https://www.commondreams.org/news/2021/11/03/progressives-virginia-loss-corporate-democrats-have-only-themselves-blame Subscribe to the Podcast: via YouTube via iTunes via TuneIn via Google Podcasts via Spotify Music: 78 & 45 archive: https://archive.org/details/georgeblood SFX: http://soundbible.com/ Purple Planet http://www.Purple-Planet.com Like us on Facebook: https://www.facebook.com/OMRPodcast/

Dews news 11/4 SPONSOR: ADAMMALE.COM USE THIS OFFER CODE AT CHECK-OUT: DEWEY STORE: https://bit.ly/3mATTDJ The Dewey Show: LISTEN/SOCIAL MEDIA: https://bit.ly/2ZN1xSO MAKE A ONE TIME DONATION TO THE SHOW: https://cash.app/$robedude *ALL DONATIONS MADE ARE NON-REFUNDABLE* CONTACT: deweyshow@aol.com Sources Businesses have until after the holidays to implement Biden Covid vaccine mandate: https://cnb.cx/3mJAvEH U.K. becomes first country to approve Merck's Covid-19 antiviral pill: https://nbcnews.to/3BOQ5TQ Ahmaud Arbery: judge seats nearly all-white jury in Georgia murder trial: https://bit.ly/3mJ78Cm

Julia Chatterley is live from New York. Here are the top business news stories today!  Taper time! Stocks rise even as fed slows stimulus support. COP contradictions! Nations unite to curb fossil fuels, as Biden tells OPEC - pump more oil. Merck's magic! The pharma giant's Covid pill approved by UK regulators. It's Thursday, let's make a move.  To learn more about how CNN protects listener privacy, visit cnn.com/privacy

Trash begins to pile up in NYC because sanitation workers are unpaid for not complying with vaccination rules // Britain approves Merck's COVID-19 pill // Unemployment claims drop to 269,000 // 15 parking spaces at Long Beach City College to be reserved for homeless students // Dwayne ‘The Rock' Johnson vows to stop using real guns on movie sets // Phoenix Suns owner Robert Sarver accused of racism and misogyny.

India successfully tested its surface-to-surface ballistic missile Agni-5 on Wednesday. According to a statement by the Ministry of Defence, it can strike targets at ranges up to 5,000km with a very high degree of accuracy. The successful test of Agni-5, which can carry nuclear bombs, is in line with India's stated policy to have credible minimum deterrence that underpins the commitment to ‘no first use,' the defence ministry said in the statement. Merck, an American drug company, will give out the formula for its Covid-19 pill—which could potentially save lives among those at higher risk of hospitalisation from the coronavirus infection—to other pharmaceutical companies worldwide. The drug, known as Molnupiravir, has shown promise in treating the disease. Merck signed the first agreement to license its production with the Medicines Patent Pool—a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. China has built a quantum computer 10 million times faster than Google's Sycamore, reports Indiatimes. Created by researchers from the University of Science and Technology of China and led by Pan Jianwei, the quantum computing system is called, Zuchongzhi 2.1—after a mathematician from the 5th century. The world's biggest tech companies including Google, IBM and Honeywell, as well as several startups are in a race to build commercial quantum computers that use qubits, which can exhibit multiple quantum states rather than the binary states of 1 and 0 in current computers. Snap has hit 100 million monthly active users in India of the Snapchat app, co-founder and CEO Evan Spiegel said in a virtual event on Wednesday. According to a report by TechCrunch, the company is striking deals with Android smartphone makers, TV channels Sony and Zee TV and e-commerce company Flipkart to expand its reach in the subcontinent. Snap has over 500 million monthly active users worldwide. Acko has raised $255 million in a new funding round led by General Atlantic and Multiples Private Equity, valuing the four-year-old insurance company at $1.1 billion, Economic Times reports. Canada's largest pension fund, CPPIB, and Lightspeed Growth as well as existing investors Intact Ventures and Munich Re Ventures also participated in the funding round. Acko will use the money to expand into health insurance, according to ET. (3:22) Interview: Mohit Yadav, co-founder of REVOS on a peer-to-peer charging network India is on the cusp of an EV revolution and several emerging startups are building various parts of the ecosystem. In today's interview, Mohit Yadav, co-founder of REVOS tells Forbes India about his company's efforts to build a peer-to-peer charging network with a smart-socket based charging point that can be used across different makes of vehicles. The P2P network also allows users to make some money by sharing their electricity.

Plus: General Motors profit sinks amid computer-chip shortage. Merck's Covid-19 pill licensed to U.N.-backed nonprofit to increase global supplies. J.R. Whalen reports. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, in our continuing series looking at the latest medical research and news on COVID-19, we speak with Dr. Kimberly Shriner from Huntington Hospital in Pasadena. Today's topics include: F.D.A. to allow ‘mix and match' approach for COVID-19 booster shots  What is “molnupiravir,” Merck's COVID-19 treatment pill?  What we know about AY.4.2, a Delta subvariant that's spiking cases in the UK  Tuberculosis, like COVID-19, spreads in aerosols, scientists report  California now only state to improve to 'moderate' level of COVID-19 transmission, CDC says  This program is made possible in part by the Corporation for Public Broadcasting, a private corporation funded by the American people.

0:48 World View "Early Landing" and mad lib (Oct 11 Hour 1) 4:11 Ted Maxwell, SALC President on Prop 206 (Oct 11 Hour 3) 14:50 Grover Norquist on the debt deal and news from DC (Oct 12 Hour 2) 28:10 Dan Shearer, GV News on Pima County Constable phase out (Oct 13 Hour 1) 37:27 Brad Hahn, Solidarity Health Share on Merck's COVID drug (Oct 13, Hour 2) 40:10 Congressman David Schweikert on supply chain backlogs and Dem policies driving return to coal & inflation (Oct 14 Hour 2) 46:47 Cecily Wong, co-author of "Gastro Obscura: A Food Adventurer's Guide". Historical info and food recommendations around the globe (Oct 15 Hour 2)

Former FDA chief Dr. Scott Gottlieb explains why he thinks Merck's Covid pill could “make a real difference.” CNBC's Phil Lebeau reports on Southwest Airlines and why the company cancelled thousands of flights over the weekend. NBC News Legal Analyst Danny Cevallos delivers his insights on the upcoming trial of Lev Parnas, Rudy Giuliani's former associate. CNBC's Steve Liesman updates on the nationwide labor shortage. CNBC's Perry Russom reports on the NBA's upcoming season and why Kyrie Irving may have to sit out roughly half of all games due to vaccine mandates. Plus, theoretical physicist Michio Kaku explains solar flares and how they could potentially cause issues on Earth.

You get sick with COVID-19. Instead of quarantining and hoping you don't get worse, or heading into the hospital, you can simply call your doctor, get a prescription, and take it at home. Seems too good to be true. But is it the future of COVID-19 treatment? Merck is hoping their new antiviral will do just that. The company officially submitted an application Monday to the FDA for emergency use authorization, for what would be the first pill to treat COVID-19. This pill, molnupiravir, has been called everything from a "game changer" to "blockbuster." The approval could come in a matter of weeks. But is it all it's been talked up to be? On this week's episode, William Schaffner, MD, a professor of preventive medicine and infectious diseases at Vanderbilt University in Nashville, helps explain what the new pill means in the fight against COVID-19, and what to watch for as it moves toward emergency use.

Jim Cramer and David Faber led off the show with a look at what investors should do in wake of the recent rally in energy prices: WTI crude surging to a seven-year high and natural gas up 50% over the past three months. The anchors highlighted Goldman Sachs lowering its U.S. growth forecasts for 2021 and 2022 as the firm expects a "delayed recovery in consumer spending" and no improvement in the global chip supply until next year. Jim and David also discussed a rough start for Southwest: Shares under pressure after the airline announced hundreds of additional flight cancellations on top of the 1,800 that took place over the weekend, citing bad weather, air traffic control issues and staff shortages. Southwest also disputes speculation that its high level of cancellations compared to other airlines were due to employee protests of a COVID-19 vaccine mandate. Speaking of the pandemic, Merck and Ridgeback Biotherapeutics announced submission of an emergency use authorization application to the FDA for their oral COVID-19 treatment. The anchors reacted to what former FDA Commissioner Dr. Scott Gottlieb told CNBC about when he believes Merck's COVID pill will hit the markets. Changes at the top of KKR: Co-founders Henry Kravis and George Roberts stepped down as Co-CEOs of the private equity firm. The anchors explored what this means for KKR and the world of P.E. Also in focus: Big banks kicking off earnings season later this week, Chinese stocks continue to rebound, Emerson Electric's $11-billion merger deal with Aspen Technology, and as movie theaters look to rebound from the pandemic -- the new James Bond film "No Time To Die" debuts by grossing $56-million at the box office domestically. It was the weekend's top performer but just shy of consensus estimates.

This episode is also available as a blog post: http://cloudhedges.com/2021/10/08/proceed-with-caution-at-your-own-peril-mercks-covid-super-drug-poses-serious-health-risks-scientists-warn/ --- Support this podcast: https://anchor.fm/cloudhedges/support

Peter Quigley, President and CEO of Kelly, discusses the jobs September report and employment trends. Bloomberg News U.S. Health Care Reporter Riley Griffin explains how Merck's Covid pill faces a risk that the virus could outsmart it. Bloomberg News Financial Investigations Reporter Caleb Melby shares his Businessweek Magazine story New York's Real Estate Tax Breaks Are Now a Rich-Kid Loophole. Dartmouth Professor of Economics Danny Blanchflower talks about seeing a U.S. recession if the history of consumer sentiment repeats. Eric Ervin, CIO at Onramp Invest, breaks down understanding and owning cryptocurrencies. And we Drive to the Close with Alan Lancz, Research Director at www.LanczGlobal.com. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Peter Quigley, President and CEO of Kelly, discusses the jobs September report and employment trends. Bloomberg News U.S. Health Care Reporter Riley Griffin explains how Merck's Covid pill faces a risk that the virus could outsmart it. Bloomberg News Financial Investigations Reporter Caleb Melby shares his Businessweek Magazine story New York's Real Estate Tax Breaks Are Now a Rich-Kid Loophole. Dartmouth Professor of Economics Danny Blanchflower talks about seeing a U.S. recession if the history of consumer sentiment repeats. Eric Ervin, CIO at Onramp Invest, breaks down understanding and owning cryptocurrencies. And we Drive to the Close with Alan Lancz, Research Director at www.LanczGlobal.com. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

This week’s 9:30 Sunday morning COVID-19 segment features Dr. Kevin Most, Chief Medical Officer at Northwestern Central DuPage Hospital. Dr. Most says he has “local optimism” for COVID cases and says vaccinations numbers are up. Dean asks Dr. Most about the details on Merck’s new COVID-19 pills. Dr. Most answers calls and questions from listeners.

Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses Merck's Covid drug reportedly reducing hospitalization and deaths. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Atlanta Bureau Chief Brett Pulley share Brett's Businessweek Magazine story Atlanta's Wealthiest and Whitest District Wants to Secede. Bloomberg News Digital News Executive Editor Joe Weisenthal explains how the trillion-dollar coin avoids a constitutional crisis. Juthica Chou, Head of OTC Options Trading at Kraken, talks about Bitcoin volatility. And we Drive to the Close with Anu Gaggar, Global Investment Strategist at Commonwealth Financial Network. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses Merck's Covid drug reportedly reducing hospitalization and deaths. Bloomberg Businessweek Editor Joel Weber and Bloomberg News Atlanta Bureau Chief Brett Pulley share Brett's Businessweek Magazine story Atlanta's Wealthiest and Whitest District Wants to Secede. Bloomberg News Digital News Executive Editor Joe Weisenthal explains how the trillion-dollar coin avoids a constitutional crisis. Juthica Chou, Head of OTC Options Trading at Kraken, talks about Bitcoin volatility. And we Drive to the Close with Anu Gaggar, Global Investment Strategist at Commonwealth Financial Network. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Merck and Ridgeback Biotherapeutics have developed a therapeutic pill for Covid that reduces the risk of hospitalization or death by around 50% for patients with mild or moderate cases. CNBC's Meg Tirrell reports that Merck hopes for emergency use authorization after “compelling results” in trials. Dr. Scott Gottlieb, former FDA commissioner, also discusses Merck's late-stage data and says it's a ‘profound game changer'. Billionaire investor Marc Lasry has resigned as chairman of Ozy Media, just three weeks to the day after he took the job, and less than a week since the digital news startup's deceptive marketing methods came to light. Ben Smith, the New York Times media columnist who broke the first story, discusses the Ozy drama. Facebook's global head of safety spoke to Instagram's impact on teenagers' mental health at a Senate subcommittee hearing. Senators compared Facebook to the tobacco industry for going after teens and children with a product they know is harmful to their health.In this episode:Ben Smith, @benytScott Gottlieb, @ScottGottliebMDMeg Tirrell, @megtirrellJoe Kernen, @JoeSquawkBecky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkin